PZJ

Lynch Syndrome Test System

Product code
PZJ
Device name
Lynch Syndrome Test System
Device class
Class 2
21 CFR
21 CFR 864.1866
Medical specialty
Immunology
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
4 (all years; only the last 3 years are listed here)

FDA classification definition

The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: PZJ
Classification and pathway per current FDA publications. Data from openFDA (CC0).